Evidence map›Paper›PMID 29267213›Full record

ArticleInternational journal of molecular sciences2017

Praeruptorin A Inhibits Human Cervical Cancer Cell Growth and Invasion by Suppressing MMP-2 Expression and ERK1/2 Signaling.

Min-Hua Wu, Chia-Liang Lin, Hui-Ling Chiou, Shun-Fa Yang, Ching-Yi Lin, Chung-Jung Liu, Yi-Hsien Hsieh

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
5.0field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 93 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 1 country.

Min-Hua WuInstitute of Medicine, Chung Shan Medical University, Taichung 40201, Taiwan. 3150@ccgh.com.tw.
Chia-Liang LinInstitute of Biochemistry, Microbiology and Immunology, Chung Shan Medical University, Taichung 40201, Taiwan. hiking0210001@gmail.com.
Hui-Ling ChiouSchool of Medical Laboratory and Biotechnology, Chung Shan Medical University, Taichung 40201, Taiwan. hlchiou@csmu.edu.tw.
Shun-Fa YangInstitute of Medicine, Chung Shan Medical University, Taichung 40201, Taiwan. ysf@csmu.edu.tw.
Ching-Yi LinDivision of Chest Medicine, Department of Internal Medicine, Taichung Veterans General Hospital, Taichung 40201, Taiwan. chingyii@vghtc.gov.tw.
Chung-Jung LiuDivision of Gastroenterology, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung 80708, Taiwan. 1020590@ms.kmuh.org.tw.
Yi-Hsien HsiehInstitute of Biochemistry, Microbiology and Immunology, Chung Shan Medical University, Taichung 40201, Taiwan. hyhsien@csmu.edu.tw.
Chung Shan Medical University Hospital · TWTaichung Veterans General Hospital · TWCheng Ching Hospital · TWChung Shan Medical University · TWKaohsiung Medical University · TW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Praeruptorin A (PA) is a pyranocumarin present in the dried root of Peucedanumpraeruptorum Dunn that has anticancer effects against several types of cells. However, the effect of PA on human cervical cancer cells is unknown. Our results indicate that PA significantly inhibited cell proliferation, colony formation, migration, invasion, and wound closure of HeLa and SiHa cells, induced cell cycle arrest at G0/G1 phase, upregulated Rb, p16, p21 and p27 proteins and downregulated cyclin D1 and S-phase kinase-associated protein 2 (Skp2) proteins. PA also significantly reduced expression of matrix metalloproteinase-2 (MMP-2) and increased expression of tissue inhibitor of metalloproteinase-2 (TIMP-2). In addition, PA suppressed ERK1/2 activation and increased the effect of PD98059 (a specific MEK1/2 inhibitor) in downregulation of MMP-2 and upregulation of TIMP-2. PA treatment inhibited the effect of 12-

Indexed as

Antineoplastic AgentsCell Cycle CheckpointsCell Line, TumorCell MovementCell ProliferationCoumarinsDrugs, Chinese HerbalFemaleFlavonoidsHeLa CellsHumansMAP Kinase Signaling SystemMatrix Metalloproteinase 2Matrix Metalloproteinase InhibitorsProtein Kinase InhibitorsSignal Transduction2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-oneAntineoplastic AgentsCoumarinsDrugs, Chinese HerbalFlavonoidsMatrix Metalloproteinase 2Matrix Metalloproteinase Inhibitorspraeruptorin AProtein Kinase InhibitorsTetradecanoylphorbol AcetateTIMP2 protein, humanTissue Inhibitor of Metalloproteinase-2cervical cancer cellsERK1/2invasionMMP-2Praeruptorin ATIMP-2

Identifiers

PMID29267213
PMCPMC5795962
OpenAlexW2757019547

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.